As of: February 9, 2024, 11:23 a.m
Comments
Press
Split
The Zeiss company logo hangs on the Zeiss Meditec AG factory.
© Stefan Puchner/dpa/archive image
The medical technology group Carl Zeiss Meditec started the new financial year cautiously due to the reduction of inventories in China and exchange rate effects.
Sales in the first quarter of the financial year that began in October rose by one percent to 475 million euros, as the company, which is listed in the MDax of the Frankfurt Stock Exchange, announced on Friday in Jena.
Jena - Adjusted for currency effects, there was an increase of 3.3 percent.
Earnings before interest and taxes (EBIT) fell from 60.3 million euros in the same period last year to around 43.5 million euros.
“The supply chains have now calmed down,” said CEO Markus Weber in Jena.
He assumes that the special effect of the reduction in inventories will still have an impact in the second quarter.
“We made it clear last summer that this temporary effect existed.” The board confirmed its forecast that the ophthalmology specialist’s sales would be at least at the level of market growth.
In addition, the second half of the year will be more profitable.
The Thuringian group employs around 4,800 people at home and abroad, including more than 2,200 in Germany.
Zeiss Meditec specializes in lasers, surgical microscopes, devices and artificial lenses for the treatment of eye diseases.
dpa